External reference pricing goes global
This article was originally published in Scrip
Do you know how drug prices are set in Guam, Kiribati or Micronesia? Or whether countries like Bhutan, Papua New Guinea and Uzbekistan use external reference pricing (ERP)? If not, you're in good company. The World Health Organization and Health Action International have no idea either, and have asked people living in 39 countries around the world to let them know whether they operate any kind of drug pricing systems, and if so whether these include ERP.
You may also be interested in...
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.